← FDA Drug Approvals (Drugs@FDA)

VOSTALLY

NDA · New Drug Application · Sponsor: ROSEMONT PHARMS · Approved 2025-07-23

Drug application

FDA Application #

NDA219757

Application type

New Drug Application

Brand name

VOSTALLY

Generic name

Ramipril

Active ingredients

RAMIPRIL

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

ROSEMONT PHARMS

First approval

2025-07-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown